You are using an outdated browser. Please upgrade your browser to improve your experience.
The Latisse® treatment is the first and only Health Canada and FDA approved prescription treatment for inadequate eyelashes. When used as recommended, Latisse® treatments promote the growth of completely natural, longer, thicker and darker eyelashes.
The Latisse® treatment is an eyelash growth formula with an active ingredient known as bimatoprost. This essential ingredient, originally used to treat glaucoma patients, in combination with other substances affects the eyelash growth cycle in two ways:
The Latisse® treatment is a topical, take-home, prescription medication that is generally applied along the base of the upper eyelashes once daily. Patients usually start to notice the results within the first 4 to 6 weeks with continuous and gradual improvements and will achieve full growth after 16 weeks of use. When the treatment is discontinued, lashes gradually return to their previous appearance.
This medication was specifically developed to treat hypotrichosis, a medical term for inadequate eyelashes. Individuals who use Latisse® treatments for at least 16 weeks are able to obtain longer, thicker eyelashes that are naturally darker. Latisse® treatment use is associated with the potential for rare side effects, such as reversible lid pigmentation, that will be covered during a consultation with our eye doctors in Maple Ridge.
Latisse® treatments can only be prescribed by a medical professional and are available for purchase through Maple Ridge Eye Care. To find out if you are a candidate for this medication, please contact our office at (604) 463-4469 to schedule your one-on-one consultation appointment.
If you are a current patient of our practice already using the Latisse® treatment and would like to order more, please call our office or complete our online reorder form.
Latisse® is a registered trademark of Allergan Inc.